BN Business News
Add your company to Business Communicator →

Business · 15/05/2003

FDA Approves New Xylazine Dosage for Elk and Wild Deer Sedation

The FDA is amending its regulations to allow for the use of a 300mg/mL xylazine hydrochloride solution in elk and wild deer for sedation, with a shorter duration of analgesia, and includes a food safety warning for currently approved products.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights